Basic Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Aug 21, 2021; 27(31): 5219-5231
Published online Aug 21, 2021. doi: 10.3748/wjg.v27.i31.5219
Figure 1
Figure 1 Model projections of future prevalence of chronic hepatitis C virus in the Republic of Cyprus under different scenarios for the total infected population, the general population (i. e. total infected population minus infected people who inject drugs), and the infected people who inject drugs. Α: Total population; Β: General population (GP); C: People who inject drugs (PWID). CI: Confidence interval.
Figure 2
Figure 2 Model predictions for cumulative hepatitis C virus related deaths in the Republic of Cyprus under different scenarios.
Figure 3
Figure 3 Model predictions for hepatitis C virus new cases (incidence) among people who inject drugs in the Republic of Cyprus under different scenarios. HCV: Hepatitis C virus.
Figure 4
Figure 4 Model estimations concerning the cumulative and annual number of antiviral treatments of each scenario. A: Cumulative treatments; B: Annual treatments.